MedCana Highlights Recent Acquisitions and the Multiple Cannabis Licenses Associated with Each
MedCana (OTC PINK:SFWJ), a global infrastructure holding company in the pharmaceutical-grade cannabis industry, has announced multiple acquisitions and associated cannabis licenses. The company has acquired a total of 23 licenses, including 7 CBD licenses, 7 THC licenses, 7 licenses for fabrication of cannabis-containing products, and 2 genetics licenses. These acquisitions will add $1.6 million to MedCana's total assets for the 3rd Quarter.
The acquisitions include 100% ownership of several companies: Cannabicolombia group s.a.s., Cannehealth Business s.a.s., Organic Leaves S.A.S., Remedium S.A.S, Royal Cannabis S.A.S, Vital Cannabis S.A.S, and Elemental Genetics S.A.S. Additionally, MedCana has acquired a controlling stake in Eko2o Environmental Solutions S.A.S., a company focused on developing infrastructure for agriculture in Colombia and South America.
MedCana (OTC PINK:SFWJ), un'azienda globale di infrastrutture nel settore della cannabis di grado farmaceutico, ha annunciato numerose acquisizioni e relativi permessi per la cannabis. L'azienda ha acquisito un totale di 23 licenze, incluse 7 licenze per il CBD, 7 licenze per il THC, 7 licenze per la fabbricazione di prodotti contenenti cannabis e 2 licenze di genetica. Queste acquisizioni aggiungeranno 1,6 milioni di dollari agli attivi totali di MedCana per il 3° trimestre.
Le acquisizioni comprendono il 100% di proprietà di diverse aziende: Cannabicolombia group s.a.s., Cannehealth Business s.a.s., Organic Leaves S.A.S., Remedium S.A.S, Royal Cannabis S.A.S, Vital Cannabis S.A.S e Elemental Genetics S.A.S. Inoltre, MedCana ha acquisito una partecipazione di controllo in Eko2o Environmental Solutions S.A.S., un'azienda focalizzata sullo sviluppo di infrastrutture per l'agricoltura in Colombia e in Sud America.
MedCana (OTC PINK:SFWJ), una empresa global de infraestructura en la industria del cannabis de grado farmacéutico, ha anunciado múltiples adquisiciones y licencias de cannabis asociadas. La compañía ha adquirido un total de 23 licencias, incluyendo 7 licencias de CBD, 7 licencias de THC, 7 licencias para la fabricación de productos que contienen cannabis y 2 licencias de genética. Estas adquisiciones agregarán $1.6 millones a los activos totales de MedCana para el 3er trimestre.
Las adquisiciones incluyen la propiedad del 100% de varias empresas: Cannabicolombia group s.a.s., Cannehealth Business s.a.s., Organic Leaves S.A.S., Remedium S.A.S, Royal Cannabis S.A.S, Vital Cannabis S.A.S y Elemental Genetics S.A.S. Además, MedCana ha adquirido una participación de control en Eko2o Environmental Solutions S.A.S., una empresa enfocada en desarrollar infraestructura para la agricultura en Colombia y América del Sur.
메드카나(OTC PINK:SFWJ), 제약 등급의 대마 산업에 있는 글로벌 인프라 홀딩 회사가 여러 획득 및 관련 대마 라이센스을 발표했습니다. 이 회사는 총 23개의 라이센스를 인수했으며, 여기에는 7개의 CBD 라이센스, 7개의 THC 라이센스, 7개의 대마 포함 제품 제조 라이센스, 그리고 2개의 유전자 라이센스가 포함됩니다. 이러한 인수는 3분기 동안 메드카나의 총 자산에 160만 달러를 추가할 것입니다.
이번 인수에는 여러 회사의 100% 소유권이 포함됩니다: Cannabicolombia group s.a.s., Cannehealth Business s.a.s., Organic Leaves S.A.S., Remedium S.A.S, Royal Cannabis S.A.S, Vital Cannabis S.A.S 및 Elemental Genetics S.A.S. 또한 메드카나는 콜롬비아와 남미의 농업 인프라 개발에 집중하는 Eko2o Environmental Solutions S.A.S.의 지배 지분을 인수했습니다.
MedCana (OTC PINK:SFWJ), une société mondiale de holding d'infrastructure dans l'industrie du cannabis de qualité pharmaceutique, a annoncé plusieurs acquisitions et licences de cannabis associées. L'entreprise a acquis un total de 23 licences, y compris 7 licences de CBD, 7 licences de THC, 7 licences pour la fabrication de produits contenant du cannabis, et 2 licences en génétique. Ces acquisitions ajouteront 1,6 million de dollars aux actifs totaux de MedCana pour le 3ème trimestre.
Les acquisitions comprennent 100% de propriété de plusieurs entreprises : Cannabicolombia group s.a.s., Cannehealth Business s.a.s., Organic Leaves S.A.S., Remedium S.A.S, Royal Cannabis S.A.S, Vital Cannabis S.A.S, et Elemental Genetics S.A.S. De plus, MedCana a acquis une participation de contrôle dans Eko2o Environmental Solutions S.A.S., une entreprise axée sur le développement d'infrastructures pour l'agriculture en Colombie et en Amérique du Sud.
MedCana (OTC PINK:SFWJ), ein globales Infrastruktur-Holdingunternehmen in der pharmazeutischen Cannabisindustrie, hat mehrere Übernahmen und zugehörige Cannabis-Lizenzen angekündigt. Das Unternehmen hat insgesamt 23 Lizenzen erworben, darunter 7 CBD-Lizenzen, 7 THC-Lizenzen, 7 Lizenzen zur Herstellung cannabishaltiger Produkte und 2 Genetik-Lizenzen. Diese Übernahmen werden 1,6 Millionen Dollar zu den Gesamtaktiva von MedCana für das 3. Quartal hinzufügen.
Zu den Übernahmen gehört 100% Eigentum an mehreren Unternehmen: Cannabicolombia group s.a.s., Cannehealth Business s.a.s., Organic Leaves S.A.S., Remedium S.A.S, Royal Cannabis S.A.S, Vital Cannabis S.A.S und Elemental Genetics S.A.S. Darüber hinaus hat MedCana eine Mehrheitsbeteiligung an Eko2o Environmental Solutions S.A.S. erworben, einem Unternehmen, das sich auf die Entwicklung der Infrastruktur für die Landwirtschaft in Kolumbien und Südamerika konzentriert.
- Acquisition of 23 cannabis licenses across various categories
- Addition of $1.6 million to total assets for the 3rd Quarter
- 100% acquisition of seven cannabis-related companies
- Controlling stake in Eko2o Environmental Solutions S.A.S., expanding into agricultural infrastructure
- None.
The licenses will add
AUSTIN, TX / ACCESSWIRE / October 9, 2024 / MedCana (OTC PINK:SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, proudly announces significant and multiple acquisitions, along with multiple cannabis licenses associated with each, bolstering the company's cannabis portfolio globally.
With these recent acquisitions, MedCana has rapidly solidified its position as a leading force in the Cannabis industry. Due to the large number of acquisitions completed, the company would like to break down each acquisition and the cannabis license associated with each to give shareholders a better idea of the scope and magnitude of these new additions to the MedCana portfolio.
MedCana has acquired a total of 23 licenses comprising:
7 CBD Licenses: Produce, Process, Sell
7 THC Licenses: Produce, Process, Sell
7 Licenses: Fabrication of products containing Cannabis
2 License: Genetics
Cannabicolombia group s.a.s.
Medcana has also acquired a controlling stake in Eko2o Environmental Solutions S.A.S. of Medellin, Antioquia. This company is focused on developing infrastructure for agriculture, primarily greenhouse construction and irrigation systems in Colombia and South America. The company recently announced its continued growth and expansion as a critical infrastructure supplier for some of Colombia's largest flower producers. The company also enhances its support and sales operations with international partnerships, notably Danziger International.
Gabriel Diaz, CEO of MedCana, commented: "The acquisitions we have made put Medcana in a position to succeed and ensure profitably."
This marks a new era in MedCana's operations as the company continues to build its presence on the global stage and explore further avenues for offering its premium cannabis products.
About SFWJ/Medcana
Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for the future growth of its holdings.
For more information, please visit: www.MedCana.net
Or connect with us via:
MedCana | LinkedIn
https://X.com/@MedcanaCo
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Jose Gabriel Diaz, CEO
www.medcana.net
info@medcana.co
SOURCE: Software Effective Solutions
View the original press release on accesswire.com
FAQ
How many cannabis licenses has MedCana (SFWJ) acquired in its recent acquisitions?
What is the financial impact of MedCana's (SFWJ) recent acquisitions on its assets?
Which companies has MedCana (SFWJ) fully acquired in its recent expansion?